...
首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >The Use of Immunohistochemical Expression of SF-1 and EMA in Distinguishing Adrenocortical Tumors From Renal Neoplasms
【24h】

The Use of Immunohistochemical Expression of SF-1 and EMA in Distinguishing Adrenocortical Tumors From Renal Neoplasms

机译:SF-1和EMA的免疫组织化学表达在区分肾肿瘤的肾上腺皮质肿瘤中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Steroidogenic factor -1 (SF-1) is an orphan member of the nuclear hormone receptor superfamily, and is considered to play an important role in the differentiation of steroidogenic tissues. In this study, we compared the immunohistochemical stains of SF-1 and epithelial membrane antigen (EMA) in non-neoplastic adrenal tissue, and adrenal and renal tumors using tissue microarrays (TMAs). The adrenal tissue array included 19 cases of normal adrenal cortex, 22 cases of adrenal adenoma, and 20 cases of adrenal cortical carcinoma. The renal tissue array included 20 cases of each of the following types of renal cell carcinoma: clear cell, papillary, and chromophobe. In addition, 20 cases of renal oncocytoma were also included in the study. SF-1 showed positive staining in all cases (100%) of normal adrenal cortex and adrenal cortical adenoma, and in 18 (90%) cases of adrenocortical carcinoma. In renal tumors, SF-1 showed negative stains in all of oncocytoma, papillary, and chromophobe renal cell carcinoma. Only 3 out of 20 cases of clear cell renal cell carcinoma showed weak positivity in approximately 10% of tumor cells. EMA stained positively in 85%, 95%, 100%, and 95% of clear cell, papillary, chromophobe renal cell carcinomas, and oncocytomas, respectively. EMA was completely negative in the adrenal TMAs. In conclusion, SF-1 and EMA may be helpful in the differentiation of adrenal tumors from renal tumors in difficult cases.
机译:类固醇生成因子-1(SF-1)是核激素受体超家族的孤儿,被认为在类固醇生成组织的分化中起着重要作用。在这项研究中,我们使用组织微阵列(TMA)比较了非肿瘤性肾上腺组织以及肾上腺和肾肿瘤中SF-1和上皮膜抗原(EMA)的免疫组织化学染色。肾上腺组织阵列包括正常肾上腺皮质19例,肾上腺腺瘤22例和肾上腺皮质癌20例。肾脏组织阵列包括以下每种类型的肾细胞癌的20例:透明细胞,乳头状和发色团。此外,该研究还包括20例肾癌细胞瘤。 SF-1在所有正常肾上腺皮质和肾上腺皮质腺瘤病例(100%)和18例(90%)肾上腺皮质癌病例中均呈阳性染色。在肾肿瘤中,SF-1在所有的肿瘤细胞瘤,乳头状和发色性肾细胞癌中均显示阴性染色。 20例透明细胞肾细胞癌中只有3例在约10%的肿瘤细胞中显示出弱阳性。 EMA分别在透明细胞癌,乳头状癌,发色性肾细胞癌和肿瘤细胞瘤中分别有85%,95%,100%和95%阳性染色。 EMA在肾上腺TMA中完全阴性。总之,在困难病例中,SF-1和EMA可能有助于区分肾上腺肿瘤和肾肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号